Results
|
|
121.
|
Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists. [electronic resource] by
- Boyfield, I
- Brown, T H
- Coldwell, M C
- Cooper, D G
- Hadley, M S
- Hagan, J J
- Healy, M A
- Johns, A
- King, R J
- Middlemiss, D N
- Nash, D J
- Riley, G J
- Scott, E E
- Smith, S A
- Stemp, G
Producer: 19960718
In:
Journal of medicinal chemistry vol. 39
Availability: No items available.
|
|
|
122.
|
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents. [electronic resource] by
- Bromidge, S M
- Dabbs, S
- Davies, S
- Duckworth, D M
- Forbes, I T
- Jones, G E
- Jones, J
- King, F D
- Saunders, D V
- Blackburn, T P
- Holland, V
- Kennett, G A
- Lightowler, S
- Middlemiss, D N
- Riley, G J
- Trail, B
- Wood, M D
Producer: 20010118
In:
Bioorganic & medicinal chemistry letters vol. 10
Availability: No items available.
|
|
|
123.
|
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. [electronic resource] by
- Stemp, G
- Ashmeade, T
- Branch, C L
- Hadley, M S
- Hunter, A J
- Johnson, C N
- Nash, D J
- Thewlis, K M
- Vong, A K
- Austin, N E
- Jeffrey, P
- Avenell, K Y
- Boyfield, I
- Hagan, J J
- Middlemiss, D N
- Reavill, C
- Riley, G J
- Routledge, C
- Wood, M
Producer: 20000629
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
|
124.
|
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. [electronic resource] by
- Gaster, L M
- Blaney, F E
- Davies, S
- Duckworth, D M
- Ham, P
- Jenkins, S
- Jennings, A J
- Joiner, G F
- King, F D
- Mulholland, K R
- Wyman, P A
- Hagan, J J
- Hatcher, J
- Jones, B J
- Middlemiss, D N
- Price, G W
- Riley, G
- Roberts, C
- Routledge, C
- Selkirk, J
- Slade, P D
Producer: 19980501
In:
Journal of medicinal chemistry vol. 41
Availability: No items available.
|
|
|
125.
|
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent. [electronic resource] by
- Bromidge, S M
- Dabbs, S
- Davies, D T
- Davies, S
- Duckworth, D M
- Forbes, I T
- Gaster, L M
- Ham, P
- Jones, G E
- King, F D
- Mulholland, K R
- Saunders, D V
- Wyman, P A
- Blaney, F E
- Clarke, S E
- Blackburn, T P
- Holland, V
- Kennett, G A
- Lightowler, S
- Middlemiss, D N
- Trail, B
- Riley, G J
- Wood, M D
Producer: 20000413
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
|
126.
|
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. [electronic resource] by
- Reavill, C
- Taylor, S G
- Wood, M D
- Ashmeade, T
- Austin, N E
- Avenell, K Y
- Boyfield, I
- Branch, C L
- Cilia, J
- Coldwell, M C
- Hadley, M S
- Hunter, A J
- Jeffrey, P
- Jewitt, F
- Johnson, C N
- Jones, D N
- Medhurst, A D
- Middlemiss, D N
- Nash, D J
- Riley, G J
- Routledge, C
- Stemp, G
- Thewlis, K M
- Trail, B
- Vong, A K
- Hagan, J J
Producer: 20000912
In:
The Journal of pharmacology and experimental therapeutics vol. 294
Availability: No items available.
|